The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the ...

A 6-month fully remote weight-loss program tailored to veterans with serious mental illness yielded numerically greater ...

By taking into account a patient’s unique biology, psychology, environment and behaviors, Hims & Hers is able to offer access ...

WW International ( WW ), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

Researchers have found in a new study that among adults with prediabetes and overweight or obesity, a fully automated, AI-led ...